Knight Therapeutics | Fortjeneste Per Aksje



Fiscal Kalender Faktiske Snittforvetning Forrige Dato
-0.23 -0.01 -0.13 Mar/21 2024
FY2023Q3 Sep/2023 0.09 -0.03 0.01 Nov/09 2023
FY2023Q2 Jun/2023 0.02 0.01 0.02 Aug/10 2023
FY2023Q1 Mar/2023 -0.04 -0.06 -0.16 May/11 2023
FY2022Q4 Dec/2022 -0.13 -0.07 Mar/23 2023
FY2022Q3 Sep/2022 0.01 -0.05 -0.07 Nov/10 2022
FY2022Q2 Jun/2022 0.02 -0.03 0.23 Aug/11 2022
FY2022Q1 Mar/2022 -0.16 -0.04 0.03 May/12 2022
FY2021Q4 Dec/2021 -0.07 0.06 Mar/24 2022
FY2021Q3 Sep/2021 -0.07 0.02 0.14 Nov/11 2021
FY2021Q2 Jun/2021 0.23 -0.08 0.13 Aug/13 2021
FY2021Q1 Mar/2021 0.03 -0.02 -0.01 May/14 2021

Eps Endring Dato
Acasti Pharma CAD -0.36 0.06 2024-12
Alaunos Therapeutics USD -0.7 0.01 2024-09
Aurora Cannabis CAD 0.58 0.8 2024-12
Avita Medical USD -0.21 0.05 2024-12
Canopy Growth CAD -1.11 0.37 2024-12
Cronos Group USD 0.11 0.09 2024-12
Dianthus Therapeutics USD -0.81 0.07 2024-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
IQVIA Holdings USD 3.12 0.28 2024-12
Knight Therapeutics CAD 0 0.02 2024-09
Moderna USD -2.91 2.94 2024-12
Organigram Holdings CAD -0.2 0.12 2024-12
Organon & Co USD 0.9 0.48 2024-12
Revvity USD 1.42 0.14 2024-12
Tectonic Therapeutic USD -0.84 0.36 2024-12
Tilray USD -1.24 1.14 2025-03
Viatris USD 0.54 0.21 2024-12
Xeris Pharmaceuticals USD -0.03 0.08 2024-12



Knight Therapeutics Fortjeneste Per Aksje - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.